(Q33327121)

25 July 2017

1 reference

title

The European approach to in-transit melanoma lesions (English)

1 reference

25 July 2017

H J Hoekstra

1

1 reference

25 July 2017

publication date

1 May 2008

1 reference

International Journal of Hyperthermia

25 July 2017

published in

1 reference

25 July 2017

volume

24

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

227-237

1 reference

Cutaneous malignant melanoma in Europe.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Follow-up in patients with localised primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Educational tips in the treatment of malignant ulcerating tumours of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Frequency and duration of remission after isolated limb perfusion for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02656730701816402

Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD005413.PUB2

Identifiers

DOI

10.1080/02656730701816402

1 reference

25 July 2017

1 reference